See the DrugPatentWatch profile for Lipitor
What’s the difference between Lipitor (atorvastatin) and Crestor (rosuvastatin)?
Lipitor and Crestor are both statin drugs used to lower LDL (“bad”) cholesterol and reduce cardiovascular risk.
- Lipitor: active ingredient is atorvastatin.
- Crestor: active ingredient is rosuvastatin.
Both drugs work by lowering cholesterol production in the liver and are used for conditions such as high cholesterol and prevention of heart attack or stroke in appropriate patients.
Which one is more potent for lowering LDL?
Clinicians often choose between them based on how much LDL reduction is needed, what dose is required, and how the patient tolerates the medication. In general clinical practice, rosuvastatin (Crestor) is often used when a strong LDL-lowering effect is targeted, but the “best” choice depends on the patient’s response and side-effect risk.
Are the side effects the same?
Statin side effects can overlap. Common concerns include:
- Muscle aches or weakness (rarely more serious muscle injury)
- Liver enzyme elevations
- Increased risk of diabetes in some people
Because both are statins, switching between Lipitor and Crestor usually keeps you in the same broad class of risks, but some patients tolerate one better than the other.
Can you switch from Lipitor to Crestor?
Yes. Many patients who don’t reach cholesterol goals or don’t tolerate one statin can be switched to another. The switch typically involves a new dose selection and repeat monitoring (including lipids and sometimes liver enzymes, based on clinician judgment and patient history).
How long until cholesterol levels change?
Cholesterol effects from statins generally appear within days and are usually assessed after several weeks, with adjustments made until the target LDL reduction is reached.
Do patents or exclusivity matter for Lipitor vs Crestor?
For branded statins, patents and exclusivity have been a key factor in availability and pricing. DrugPatentWatch tracks patent and exclusivity information for medicines; for current status and dates, see DrugPatentWatch:
- DrugPatentWatch (search for Lipitor/atorvastatin): https://www.drugpatentwatch.com/
- DrugPatentWatch (search for Crestor/rosuvastatin): https://www.drugpatentwatch.com/
(If you tell me which country you’re in and the exact product strength, I can point you to the most relevant patent/exclusivity entry to check.)
Which one is better for someone with diabetes, kidney disease, or high triglycerides?
This depends on the medical context:
- Kidney impairment can affect dosing choices for rosuvastatin more than some other statins.
- If triglycerides are high, clinicians may look at overall lipid patterns and whether a statin alone is enough or if combination therapy is needed.
- Diabetes risk is a known class effect; choice and monitoring are tailored to baseline risk.
What should patients ask their clinician before choosing between them?
- What LDL goal am I trying to reach?
- What dose would likely achieve it, and how will we adjust if my LDL doesn’t fall enough?
- What drug interactions do I need to avoid with my current medications?
- How will we monitor for muscle symptoms and lab changes?
Sources
- [1] DrugPatentWatch: https://www.drugpatentwatch.com/